MSR123 Use of real-world data in cost-effectiveness analysis of sequential biologic treatment for rheumatoid arthritis

Singh, J., Stevenson, M.D. orcid.org/0000-0002-3099-9877, Hyrich, K. et al. (3 more authors) (2022) MSR123 Use of real-world data in cost-effectiveness analysis of sequential biologic treatment for rheumatoid arthritis. In: Value in Health. ISPOR Europe 2022, 06-09 Nov 2022, Vienna, Austria. Elsevier , S373-S374.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2022 Published by Elsevier Inc.
Dates:
  • Published (online): 14 December 2022
  • Published: December 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 25 Jan 2024 17:15
Last Modified: 25 Jan 2024 17:16
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jval.2022.09.1853
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)